CDR-repaired antibodies

Details for Australian Patent Application No. 2005214382 (hide)

Owner Genentech, Inc.

Inventors Dennis, Mark S.

Agent Griffith Hack

Pub. Number AU-B-2005214382

PCT Pub. Number WO2005/080432

Priority 60/545,840 19.02.04 US

Filing date 18 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 4 August 2011

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080432 Priority application(s): WO2005/080432

4 August 2011 Application Accepted

  Published as AU-B-2005214382

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214387-Olefin oligomerization

2005214380-Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders